Voting report Legal & General Investment Management

Size: px
Start display at page:

Download "Voting report Legal & General Investment Management"

Transcription

1 July 2018 North America Voting Report Voting report Legal & General Investment Management No warranty is given and no representation is made regarding the accuracy or completeness of the content of this report, and no liability or responsibility is accepted for the information contained in this report. Registered Offce: Legal & General Investment Management Limited One Coleman Street London EC2R 5AA +44 (0) Authorised and Regulated by the Financial Conduct Authority Copyright Legal & General Investment Management 2018

2 Concho Resources Inc. Meeting Date: 07/17/2018 Primary Security ID: 20605P101 Ticker: CXO Primary ISIN: US20605P1012 Number Text Proponent Mgmt Rec 1 Issue Shares in Connection with Acquisition Constellation Brands, Inc. Meeting Date: 07/17/2018 Primary Security ID: 21036P108 Ticker: STZ Primary ISIN: US21036P1084 Number Text Proponent Mgmt Rec 1.1 Elect Director Jerry Fowden Mgmt For Withhold Blended Rationale: A vote against is applied as LGIM has had concerns with the remuneration policy for 3 years. 1.2 Elect Director Barry A. Fromberg 1.3 Elect Director Robert L. Hanson 1.4 Elect Director Ernesto M. Hernandez 1.5 Elect Director Susan Somersille Johnson 1.6 Elect Director James A. Locke, III Mgmt For Withhold Blended Rationale: A WITHHOLD vote is warranted for James Locke III for serving as a non-independent member of a key board committee. A vote against is applied as LGIM expects a board to be regularly refreshed in order to maintain independence, relevant skills, experience and diversity. 1.7 Elect Director Daniel J. McCarthy 1.8 Elect Director Richard Sands 1.9 Elect Director Robert Sands 1.10 Elect Director Judy A. Schmeling 1.11 Elect Director Keith E. Wandell Mgmt For Withhold Blended Rationale: A vote against is applied as LGIM expects a CEO or Non-Executive Directors not to hold too many external roles to ensure they can undertake their duties effectively. 2 Ratify KPMG LLP as Auditors

3 Constellation Brands, Inc. Number Text Proponent Mgmt Rec 3 Advisory to Ratify Named Executive Officers' Compensation Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects a sufficient portion of awards to be assessed against performance conditions to ensure alignment of remuneration with company performance. Nutrien Ltd. Meeting Date: 07/19/2018 Country: Canada Primary Security ID: 67077M108 Ticker: NTR Primary ISIN: CA67077M1086 Number Text Proponent Mgmt Rec 1.1 Elect Director Christopher M. Burley 1.2 Elect Director Maura J. Clark 1.3 Elect Director John W. Estey 1.4 Elect Director David C. Everitt Mgmt For Withhold Blended Rationale: A vote against is applied as LGIM expects a CEO or Non-Executive Directors not to hold too many external roles to ensure they can undertake their duties effectively. 1.5 Elect Director Russell K. Girling 1.6 Elect Director Gerald W. Grandey 1.7 Elect Director Miranda C. Hubbs 1.8 Elect Director Alice D. Laberge 1.9 Elect Director Consuelo E. Madere 1.10 Elect Director Charles "Chuck" V. Magro 1.11 Elect Director Keith G. Martell 1.12 Elect Director A. Anne McLellan 1.13 Elect Director Derek G. Pannell 1.14 Elect Director Aaron W. Regent 1.15 Elect Director Mayo M. Schmidt 1.16 Elect Director Jochen E. Tilk 2 Approve Re-appointment of KPMG LLP as Auditors

4 Nutrien Ltd. Number Text Proponent Mgmt Rec 3 Approve Stock Option Plan and Grant of Stock Options Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects a sufficient portion of awards to be assessed against performance conditions to ensure alignment of remuneration with company performance. 4 Advisory on Executive Compensation Approach VMware, Inc. Meeting Date: 07/19/2018 Primary Security ID: Ticker: VMW Primary ISIN: US Number Text Proponent Mgmt Rec 2 Advisory to Ratify Named Executive Officers' Compensation 3 Ratify PricewaterhouseCoopers LLP as Auditors McKesson Corporation Meeting Date: 07/25/2018 Primary Security ID: 58155Q103 Ticker: MCK Primary ISIN: US58155Q1031 Number Text Proponent Mgmt Rec 1a Elect Director N. Anthony Coles 1b Elect Director John H. Hammergren 1c Elect Director M. Christine Jacobs 1d Elect Director Donald R. Knauss 1e Elect Director Marie L. Knowles Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects a board to be regularly refreshed in order to maintain independence, relevant skills, experience and diversity. 1f Elect Director Bradley E. Lerman

5 McKesson Corporation Number Text Proponent Mgmt Rec 1g Elect Director Edward A. Mueller 1h Elect Director Susan R. Salka 2 Ratify Deloitte & Touche LLP as Auditors Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects the role of the external auditor to be put to tender on a regular basis. 3 Advisory to Ratify Named Executive Officers' Compensation Mgmt For For 4 Report on Lobbying Payments and Policy SH Against For Blended Rationale: A vote in favour is applied as LGIM expects companies to provide sufficient disclosure on such contributions. 5 Pro-rata Vesting of Equity Awards SH Against For Blended Rationale: A vote in favour is applied as LGIM does not support the accelerated vesting of awards as this can impact executive decision making. 6 Use GAAP for Executive Compensation SH Metrics 7 Reduce Ownership Threshold for SH Shareholders to Call Special Meeting Against Against Against For Blended Rationale: A vote in favour is applied as the resolution is seeking to reduce the threshold below 25%. GGP Inc. Meeting Date: 07/26/2018 Primary Security ID: 36174X101 Ticker: GGP Primary ISIN: US36174X1019 Number Text Proponent Mgmt Rec 1 Approve Merger Agreement 2 Authorize a New Class of Capital Stock 3 Amend Charter to Remove the Ability of Stockholders to Prohibit BPR Board from Amending the BPR Bylaws 4 Increase Supermajority Requirement for Amendments 5 Adopt or Increase Supermajority Requirement for Removal of Directors 6 Amend Bylaws to Include a Provision Requiring BPR to Include in its Proxy Statements and Proxy Cards Director Candidates Selected by a BPY Affiliate

6 GGP Inc. Number Text Proponent Mgmt Rec 7 Eliminate Right to Call Special Meeting 8 Advisory on Golden Parachutes Mgmt For Against Blended Rationale: A vote AGAINST this proposal is warranted. The CEO's outstanding equity awards are subject to automatic, single-trigger vesting. Moreover, he will receive his full cash severance despite continuing employment with similar compensation terms to his current employment. The Walt Disney Company Meeting Date: 07/27/2018 Primary Security ID: Ticker: DIS Primary ISIN: US Number Text Proponent Mgmt Rec 1 Issue Shares in Connection with Acquisition 2 Adjourn Meeting Twenty-First Century Fox, Inc. Meeting Date: 07/27/2018 Primary Security ID: 90130A101 Ticker: FOXA Primary ISIN: US90130A1016 Number Text Proponent Mgmt Rec 1 Approve Merger Agreement 2 Approve Distribution Agreement 3 Amend Charter Regarding Hook Stock 4 Adjourn Meeting 5 Advisory on Golden Parachutes Mgmt For Against Blended Rationale: A vote AGAINST this proposal is warranted. There are concerns regarding executives' very large "retention RSUs," half of which vests automatically upon the merger, that were made on top of executives' sizable golden parachute benefits. Also, certain performance equity awards were amended to vest at target without a clearly disclosed rationale or sufficient explanatory disclosure.

7 Twenty-First Century Fox, Inc. Meeting Date: 07/27/2018 Primary Security ID: 90130A101 Ticker: FOXA Primary ISIN: US90130A1016 Number Text Proponent Mgmt Rec 1 Approve Merger Agreement 2 Approve Distribution Agreement SCANA Corporation Meeting Date: 07/31/2018 Primary Security ID: 80589M102 Ticker: SCG Primary ISIN: US80589M1027 Number Text Proponent Mgmt Rec 1 Approve Merger Agreement 2 Advisory on Golden Parachutes Mgmt For Against Blended Rationale: A vote AGAINST this proposal is warranted. All equity is subject to single-trigger vesting upon the completion of the merger, including CEO Addison's performance awards granted just six months ago, which were meant to vest or be earned over three years, but will vest at target. The full acceleration of recently-granted performance awards represents a windfall opportunity. 3 Adjourn Meeting Xerox Corporation Meeting Date: 07/31/2018 Primary Security ID: Ticker: XRX Primary ISIN: US Number Text Proponent Mgmt Rec 1.1 Elect Director Gregory Q. Brown

8 Xerox Corporation Number Text Proponent Mgmt Rec 1.2 Elect Director Keith Cozza Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects a CEO or Non-Executive Directors not to hold too many external roles to ensure they can undertake their duties effectively. 1.3 Elect Director Jonathan Christodoro Mgmt For Against Blended Rationale: A vote against is applied as LGIM expects a CEO or Non-Executive Directors not to hold too many external roles to ensure they can undertake their duties effectively. 1.4 Elect Director Joseph J. Echevarria 1.5 Elect Director Nicholas Graziano 1.6 Elect Director Cheryl Gordon Krongard 1.7 Elect Director Scott Letier 1.8 Elect Director Sara Martinez Tucker 1.9 Elect Director Giovanni ('John') Visentin 2 Ratify PricewaterhouseCoopers LLP as Auditors 3 Advisory to Ratify Named Executive Officers' Compensation Mgmt For Against Blended Rationale: A vote AGAINST this proposal is warranted given that the company recently entered into an employment agreement with new CEO John Visentin that provides for problematic modified single-trigger cash severance. 4 Adjourn Meeting Mgmt For Against Blended Rationale: A vote AGAINST this proposal is warranted given that support is not warranted for Item 3.

Vote Summary Report Reporting Period: July 1, 2015 to September 30, The Fiera Capital Mutual Funds

Vote Summary Report Reporting Period: July 1, 2015 to September 30, The Fiera Capital Mutual Funds The Fiera Capital Mutual Funds 1 Contents Housing Development Finance Corp. Ltd.... 3 ATS Automation Tooling Systems Inc.... 4 Fairfax Financial Holdings Limited... 5 Tamarack Valley Energy Ltd.... 6 Lumenpulse

More information

RULES OF CONDUCT OF INSIDERS RESPECTING

RULES OF CONDUCT OF INSIDERS RESPECTING T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )

More information

SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017

SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017 SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017 Chair s Introduction Welcome Good morning and welcome to Smartpay s Annual Meeting for 2017. I m pleased to be speaking on behalf of

More information

September audit deficiency trends. acuitas, inc. concluding thoughts. pcaob s audit deficiencies by audit standard.

September audit deficiency trends. acuitas, inc. concluding thoughts. pcaob s audit deficiencies by audit standard. September 2015 home executive summary audit deficiencies pcaob inspections methodology are still significant description of a deficiency audit deficiency trends fvm deficiencies impairment deficiencies

More information

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main

More information

WALGREENS BOOTS ALLIANCE, INC.

WALGREENS BOOTS ALLIANCE, INC. WALGREENS BOOTS ALLIANCE, INC. FORM 8-K (Current report filing) Filed 01/30/17 for the Period Ending 01/26/17 Address 108 WILMOT ROAD DEERFIELD, IL 60015 Telephone (847) 315-2500 CIK 0001618921 Symbol

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

GAVI ALLIANCE STATUTES 26 March 2008

GAVI ALLIANCE STATUTES 26 March 2008 GAVI ALLIANCE STATUTES 26 March 2008 I. GENERAL PROVISIONS Article 1 Name An independent non-profit foundation within the meaning of Articles 80 et seq. of the Swiss Civil Code is referred to as the GAVI

More information

Conflict of Interest Policy

Conflict of Interest Policy Revised 10/13/2016 Conflict of Interest Policy All AMIA leaders have an obligation to make decisions and conduct affairs of the organization based, first and foremost, upon the desire to promote AMIA and

More information

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose

More information

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) December 21, 2016 Sumitomo Dainippon Pharma Co., Ltd. Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka,

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q 10-Q 1 v402511_10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934. For the

More information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement For immediate release April 28, 2005 Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement Dainippon Pharmaceutical Co., Ltd. Sumitomo Pharmaceuticals Co., Ltd. Dainippon Pharmaceutical

More information

Interim Report 1 January September 2017

Interim Report 1 January September 2017 2014-01-01 2014-12 Interim Report 1 January 2017 30 September 2017 Cantargia AB 556791-6019 Cantargia refers to Cantargia AB (publ), corporate ID number 556791-6019. Clinical trial initiated Highlights

More information

Any items to be debated or voted against must be removed from the Consent Agenda and considered separately.

Any items to be debated or voted against must be removed from the Consent Agenda and considered separately. Item Item of Business and Page Number Squamish-Lillooet Regional Hospital District Board Agenda April 27, 2016; 2:00 PM SLRD Boardroom 1350 Aster Street, Pemberton, BC Page 1. Call to Order We would like

More information

Community Benefits and the New Form 990

Community Benefits and the New Form 990 Community Benefits and the New Form 990 Anne McGeorge Grant Thornton LLP Grant Thornton LLP. All rights reserved. anne.mcgeorge@gt.com (704) 632-3520 May 7, 2008 Why Form 990 is important The public: Maintaining

More information

ANNUAL GENERAL MEETING 2016

ANNUAL GENERAL MEETING 2016 DATE: Friday 4 March 2016 TIME: 13:00 ANNUAL GENERAL MEETING 2016 VENUE: University of London, 20 Bedford Way, London WC1H 0AL Trustees present: Keith Barton, Chair Stephen Epstein Julian Exeter Yolanda

More information

Annual General Meeting 17 July 2018

Annual General Meeting 17 July 2018 Annual General Meeting 17 July 2018 Notice of Annual General Meeting Notice is hereby given that the 29th Annual General Meeting of Macmillan Cancer Support (the Charity ) will be held on Tuesday 17 July

More information

ESM MANAGEMENT COMMENTS ON BOARD OF AUDITORS ANNUAL REPORT TO THE BOARD OF GOVERNORS. for the period ended 31 December 2015

ESM MANAGEMENT COMMENTS ON BOARD OF AUDITORS ANNUAL REPORT TO THE BOARD OF GOVERNORS. for the period ended 31 December 2015 ESM MANAGEMENT COMMENTS ON BOARD OF AUDITORS ANNUAL REPORT TO THE BOARD OF GOVERNORS for the period ended 31 December 2015 2 EUROPEAN STABILITY MECHANISM Dear Chairperson, I would like to thank you for

More information

MEMORANDUM. Vincent J. Mastracco Jr., Acting Chair William P. Kanto Jr., M.D. The Hon. Lewis F. Payne

MEMORANDUM. Vincent J. Mastracco Jr., Acting Chair William P. Kanto Jr., M.D. The Hon. Lewis F. Payne July 9, 2010 MEMORANDUM TO: The Medical Center Operating Board: Vincent J. Mastracco Jr., Acting Chair William P. Kanto Jr., M.D. The Hon. Lewis F. Payne Constance R. Kincheloe Randl L. Shure Randy J.

More information

Florida Deaf-Blind Association, Inc. (FDBA) CONSTITUTION AND BL-LAWS

Florida Deaf-Blind Association, Inc. (FDBA) CONSTITUTION AND BL-LAWS Florida Deaf-Blind Association, Inc. (FDBA) CONSTITUTION AND BL-LAWS MISSION STATEMENT The mission of the Florida Deaf-Blind Association is to enable Deaf-Blind people, including all people with both hearing

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015

More information

Forward-Looking Statements

Forward-Looking Statements Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.

More information

For personal use only

For personal use only October 29 th, 2018 RotoGro to Acquire 100% of Canadian Lawful Cannabis License RotoGro to acquire 100% of the issued share capital of Supra THC from Valens GroWorks Corp. ( CSE:VGW ) Supra THC holds a

More information

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE The National Association to Advance Fat Acceptance is a nonprofit, member supported organization composed of determined

More information

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. The shareholders of the company Solvay S.A. with its corporate offices in Brussels, rue de Ransbeek, no. 310,

More information

Deloitte Touche Tohmatsu ABN 74 490 121 060 Eclipse Tower 60 Station Street Parramatta Sydney, NSW, 2150 Australia Phone: +61 2 9840 7000 www.deloitte.com.au The Board of Directors The Deaf Society Level

More information

Best Lawyers. Stewart McKelvey

Best Lawyers. Stewart McKelvey Best Lawyers Stewart McKelvey Fredericton Allison McCarthy (2012) Frederick McElman QC (2012) Richard Petrie (2006) Moncton Marie-Claude Bélanger-Richard QC (2011) Family Law Robert Dysart (2012) Medical

More information

Operational Efficiency:

Operational Efficiency: Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from

More information

ACTIVE OWNERSHIP IN THE NOVO NORDISK FOUNDATION GROUP

ACTIVE OWNERSHIP IN THE NOVO NORDISK FOUNDATION GROUP ACTIVE OWNERSHIP IN THE NOVO NORDISK FOUNDATION GROUP Sten Scheibye Chairman of the board May 7, 2014 AGENDA The Novo Nordisk Foundation Group - Introduction The Novo Nordisk Foundation Active ownership

More information

Investor Presentation June 2012 NASDAQ: CEMI

Investor Presentation June 2012 NASDAQ: CEMI Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act

More information

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Conference Call

More information

BVI Limited Partnership Hedge Funds: Calling Japan

BVI Limited Partnership Hedge Funds: Calling Japan BERMUDA BRITISH VIRGIN ISLANDS CAYMAN ISLANDS CYPRUS DUBAI HONG KONG LONDON MAURITIUS MOSCOW SÃO PAULO SINGAPORE conyersdill.com June 2012 BVI Limited Partnership Hedge Funds: Calling Japan Structuring

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

Community Mitigation Recommendations DRAFT as of November 22, 2017

Community Mitigation Recommendations DRAFT as of November 22, 2017 Special thanks to the individuals that contributed to the background and development of these recommendations. Julie Jacobson, Massachusetts Municipal Association Scott Winters, Vice Chair of the Amesbury

More information

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data

More information

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update November 3, 2016 4:05 PM ET Rucaparib New Drug Application (NDA) accepted for Priority Review in the treatment of advanced BRCA-mutant

More information

THE MS SOCIETY OF TASMANIA. Annual Report Annual Report and Financial Statements

THE MS SOCIETY OF TASMANIA. Annual Report Annual Report and Financial Statements THE MS SOCIETY OF TASMANIA and Financial Statements For the Year Ended 30 June 2016 Chairman s Report Page 2 THE MS SOCIETY OF TASMANIA I would like to commence my final Chairman s report by thanking and

More information

REGULATION (EC) No.141/2000

REGULATION (EC) No.141/2000 REGULATION (EC) No.141/2000 Community legislation in force Document 300R0141 Directory chapters where this document can be found: [15.30 Health promotion] Regulation (EC) No.141/2000 of the European Parliament

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

Gavi Alliance Conflict of Interest Policy Version 2.0

Gavi Alliance Conflict of Interest Policy Version 2.0 Version 2.0 DOCUMENT ADMINISTRATION VERSION NUMBER 1.0 APPROVAL PROCESS DATE Reviewed by: Gavi Governance Committee 15 April 2009 Approved by: Gavi Alliance Board 2.0 Prepared by: Legal and Governance

More information

CHEUNG KONG PROPERTY HOLDINGS LIMITED. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1113)

CHEUNG KONG PROPERTY HOLDINGS LIMITED. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 1113) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu 1P P Floor NHS: PCA(D)(2010)6 Primary and Community Care Directorate Primary Care Division abcdefghijklmnopqrstu Dear Colleague GENERAL DENTAL SERVICES 1. Clinical Audit Arrangements 1 August 2010 2. Listing

More information

Merrimack Pharmaceuticals: A Refocused R&D Company January 2017

Merrimack Pharmaceuticals: A Refocused R&D Company January 2017 Merrimack Pharmaceuticals: A Refocused R&D Company January 2017 Forward Looking Statements This presentation contains forward-looking statements of the Company that involve substantial risks and uncertainties.

More information

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA Situated at: 553 Madiba Street, Arcadia, Pretoria Deadline for submission:

More information

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 VICAL INC FORM 8-K (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 Address 10390 PACIFIC CENTER COURT. SAN DIEGO, CA 92121-4340 Telephone 858-646-1100 CIK 0000819050 Symbol VICL SIC

More information

Bylaws of the College of Dental Surgeons of British Columbia

Bylaws of the College of Dental Surgeons of British Columbia Bylaws of the College of Dental Surgeons of British Columbia Health Professions Act RSBC 1996, chapter 183 Dated: April 3, 2009 (consolidated December 2017) 500 1765 West 8 th Avenue Vancouver BC V6J 5C6

More information

<TABLE> <S> <C> <C> <C> <C>

<TABLE> <S> <C> <C> <C> <C> N-PX 1 brdbn70001326544.txt BRDBN70001326544.TXT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-PX ANNUAL REPORT

More information

GOVERNANCE. Governance Structures. Board of Trustees Appointment. Corporate Governance and Compliance Framework. Role. Shareholder GOVERNANCE

GOVERNANCE. Governance Structures. Board of Trustees Appointment. Corporate Governance and Compliance Framework. Role. Shareholder GOVERNANCE GOVERNANCE GOVERNANCE Corporate governance involves the establishment of structures and processes, with appropriate checks and balances that enable members of the NEF s Board of Trustees to discharge their

More information

TRAUMA RECOVERY/HAP OPERATING GUIDELINES

TRAUMA RECOVERY/HAP OPERATING GUIDELINES TRAUMA RECOVERY/HAP OPERATING GUIDELINES FOR THE NATIONAL TRAUMA RECOVERY NETWORK, THE TRAUMA RECOVERY NETWORK ASSOCIATIONS, AND THE TRAUMA RECOVERY NETWORK CHAPTERS Operating Guidelines These Operating

More information

******************************************************************* MINUTES OF SYMMES TOWNSHIP SPECIAL MEETING

******************************************************************* MINUTES OF SYMMES TOWNSHIP SPECIAL MEETING ******************************************************************* MINUTES OF SYMMES TOWNSHIP SPECIAL MEETING AUGUST 14, 2018 ******************************************************************* The meeting

More information

Leveraging Technology for the Canadian Private Target Mergers & Acquisitions Deal Points Study

Leveraging Technology for the Canadian Private Target Mergers & Acquisitions Deal Points Study Osler, Hoskin & Harcourt LLP Leveraging Technology for the Canadian Private Target Mergers & Acquisitions Deal Points Study ABA MARKET TRENDS COMMITTEE MEETING André Perey Natalie Munroe March 2019 Background

More information

TSX Venture: RVV OTCQB: RVVTF

TSX Venture: RVV OTCQB: RVVTF TSX Venture: RVV OTCQB: RVVTF The image part with relationship ID rid3 was not found in the file. 2017 Annual General and Special Meeting of Shareholders December 19, 2017 Revive Therapeutics Ltd. Office:

More information

The Dental Corporation Opportunity

The Dental Corporation Opportunity The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,

More information

Novo Nordisk has proposed to acquire Ablynx for up to per share in cash, consisting of upfront and 2.50 in Contingent Value Rights

Novo Nordisk has proposed to acquire Ablynx for up to per share in cash, consisting of upfront and 2.50 in Contingent Value Rights Novo Nordisk has proposed to acquire Ablynx for up to 30.50 per share in cash, consisting of 28.00 upfront and 2.50 in Contingent Value Rights Proposal consists of upfront cash consideration of 28.00 per

More information

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo

More information

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15. [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS

More information

New Markets Tax Credit CDE Certification Question & Answer

New Markets Tax Credit CDE Certification Question & Answer Community Development Financial Institutions Fund New Markets Tax Credit CDE Certification Question & Answer Revised July 2005 Page 1 of 10 Table of Contents General Application and Eligibility Questions

More information

A N N U A L R E P O R T

A N N U A L R E P O R T 2008 ANNUAL REPORT idera s pipeline PARTNERED PROGRAMS CANDIDATE DISEASE RESEARCH PRECLINICAL PHASE 1 PHASE 2 PARTNERS IMO-2055 (TLR9 agonist) QAX935 (TLR9 agonist) TLR7, 8, 9 agonists Oncology Renal Cell

More information

Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies

Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies 1 Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies Quyen Ngo-Metzger, MD, MPH Scientific Director, USPSTF Program Agency for Healthcare Research and Quality

More information

abcdefghijkm abcde abc a Health Department Workforce Directorate NHS Circular: PCS(DD)2006/5 Dear Colleague

abcdefghijkm abcde abc a Health Department Workforce Directorate NHS Circular: PCS(DD)2006/5 Dear Colleague abcdefghijkm Health Department Workforce Directorate NHS Circular: Dear Colleague PAY AND CONDITIONS OF SERVICE FOR DENTAL PUBLIC HEALTH, COMMUNITY DENTAL STAFF AND SALARIED GENERAL DENTAL PRACTITIONERS

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q 10-Q 1 v393825_10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

More information

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase

More information

Cochlear Limited 2007 Annual General Meeting

Cochlear Limited 2007 Annual General Meeting Cochlear Limited 2007 Annual General Meeting Australia Ballroom The Menzies Sydney Hotel 14 Carrington Street Sydney NSW Tuesday, 23rd October 2007 Mr Tommie Bergman Chairman 1 Mr Neville Mitchell Company

More information

Cultural Diversity and Community Advisory Committee Charter July

Cultural Diversity and Community Advisory Committee Charter July Cultural Diversity and Community Advisory Committee Charter July 2017-2018 Page 1 of 8 CONTENTS SECTION A: CULTURAL DIVERSITY AND COMMUNITY ADVISORY COMMITTEE CHARTER... 3 Statement of purpose... 3 1.

More information

Alpha Phi Omega, Inc.

Alpha Phi Omega, Inc. Alpha Phi Omega, Inc. General Information Contact Information Nonprofit Alpha Phi Omega, Inc. Address 1441 E 104th Street Kansas City, MO 64131 Phone (816) 373-8667 Website www.apo.org Facebook facebook.com/alphaphiomega.usa

More information

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018 Guidance for Municipalities Regarding Marijuana for Adult Use January 2018 The following information is provided to assist municipalities by addressing questions related to the regulation of marijuana

More information

*REVISED JANUARY 2018*

*REVISED JANUARY 2018* *REVISED JANUARY 2018* and Taxation of Marijuana Act (Chapter 334 of the Acts of 2016), allowing non-medical (also known as adult or recreational ) use of marijuana by adults in the Commonwealth and authorizing

More information

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director Robert Ullman Managing Director rullman@dinancapital.com 45.63.44 NORTH AMERICAN DERMATOLOGY M&A Activity and Valuation Trends Q4 205 William Downing Director wdowning@dinancapital.com 602.734.0682 Michael

More information

Title 1 Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym

Title 1 Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents* Section/item Item No Description Addressed on page number Administrative information Title 1 Descriptive

More information

After simple testing that only takes minutes people with elevated test results are then recommended to see their physicians for follow-up.

After simple testing that only takes minutes people with elevated test results are then recommended to see their physicians for follow-up. New Medical Device Company Addresses Two Very High Demand Markets with its Proprietary Products. Trader Tracks likes this company as they provide reasonably priced equipment and testing while medical costs

More information

Members present: Mr. Bill Bush, President; Mr. Fred Pries, Secretary; Mr. Dallas Osting, Member, and Mr. Jeff Oswalt, Member.

Members present: Mr. Bill Bush, President; Mr. Fred Pries, Secretary; Mr. Dallas Osting, Member, and Mr. Jeff Oswalt, Member. March 8, 2016, Work Session The Board of School Trustees of the Randolph Central School Corporation met in a Public Work Session on Tuesday, March 8, 2016, in the Board Room at the Central Office. The

More information

Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt

Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt Summary Report McKesson Corporation Page 1 of 27 Meeting Date: 07/26/2017 Country: USA Primary Security ID: 58155Q103 Record Date: 05/31/2017 Meeting Type: Annual Ticker: MCK Primary CUSIP: 58155Q103 Primary

More information

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu NHS: PCA(D)(2008)1 Primary and Community Care Directorate Primary Care Division abcdefghijklmnopqrstu Dear Colleague GENERAL DENTAL SERVICES AMENDMENT NO 110 TO THE STATEMENT OF DENTAL REMUNERATION: REVISED

More information

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results July 31, 2015 NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET- AMES, Iowa, July 31,

More information

EPC invites you to their 23 rd Annual General Meeting on Thursday 12 July 2018

EPC invites you to their 23 rd Annual General Meeting on Thursday 12 July 2018 Date Address Community House 311 Fore Street London N9 0PZ Telephone: 020 8373 6243 Email: enquiries@epandc.org.uk Web: www.epandc.org.uk Dear Sir/Madam EPC invites you to their 23 rd Annual General Meeting

More information

GROUP INFORMATION RUBRIC

GROUP INFORMATION RUBRIC 1. NAME OF GROUP: Al-Anon and Alateen 2. LENGTH OF TIME THIS GROUP HAS BEEN IN EXISTENCE: Almost as long as AA. Family groups formed as early as 1935. By 1951, the name Al-Anon Family Groups. First paid

More information

PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER

PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER 1 INTRODUCTION 1.1 The Review of Prescribing, Supply & Administration of Medicines (Crown II) Final Report was submitted to The Secretary of State for Health

More information

Investing in Dental Practice Management: Key Issues and Notable Transactions

Investing in Dental Practice Management: Key Issues and Notable Transactions Investing in Dental Practice Management: Key Issues and Notable Transactions SCOTT BECKER, PARTNER 312.750.6016 sbecker@mcguirewoods.com 77 West Wacker Drive, Suite 4100 Chicago, Illinois 60601 LAURALEE

More information

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109

More information

Town of Killam Regular Council Meeting 11

Town of Killam Regular Council Meeting 11 Town of Killam Regular Council Meeting 11 Minutes of the regular Council meeting held in Council Chambers of the Town Office, Killam, Alberta, on Thursday, March 15, 2018 commencing at 6:30pm. PRESENT

More information

Developing Xanamem for Alzheimer s Dementia

Developing Xanamem for Alzheimer s Dementia Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,

More information

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP ARTICLE I NAME AND LOGO CONSTITUTION The name of the Society is Cameroon Radiological Protection Society which is created in 28 th September 2012 may be referred to in abbreviated form as CRPS. The logo

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

ELECTIONS APPLICATION FORM WPHNA Executive Committee

ELECTIONS APPLICATION FORM WPHNA Executive Committee ELECTIONS 2017 APPLICATION FORM WPHNA Executive Committee This is the Application form for the 2017 WPHNA Elections. All queries about positions, the election process, or any other relevant matter, should

More information

Zealand Pharma A/S Interim report for Q (un-audited)

Zealand Pharma A/S Interim report for Q (un-audited) Company Announcement No. 12/2012 (un-audited) Net profit for the quarter of DKK 66 (EUR 9) million Important pipeline progress, and revenue from milestone payments of DKK 120 (EUR 16) million Cash and

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM N-PX

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM N-PX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number: 811-21113

More information

2017 Annual General Meeting

2017 Annual General Meeting Cedar Woods Presentation 1 Cedar Woods Properties Limited 2017 Annual General Meeting 9 November 2017 Cedar Woods Presentation 2 Agenda 1 Chairman s Address Mr William G Hames 2 Managing Director s Review

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Board of Directors PO Box 1 Johnson City, TX Regular Meeting

Board of Directors PO Box 1 Johnson City, TX Regular Meeting Board of Directors PO Box 1 Johnson City, TX 78636 Regular Meeting www.pec.coop ~ Final Agenda ~ Call PEC Toll Free 1-888- 554-4732 Monday, September 17, 2012 10:00 AM PEC Headquarters Auditorium 1. Call

More information

CIPHI Alberta Branch Executive Meeting February 21, :00 AM

CIPHI Alberta Branch Executive Meeting February 21, :00 AM CIPHI Executive Meeting February 21, 2004 9:00 AM Executive Present: Mah, David Crowe, Dan Richen, Keith Lee, Phi Phan, Merry Turtiak, Simon Sihota, Koreen Westly, Phil Callbeck Regrets: Jay Jorgenson,

More information

Darwin Marine Supply Base HSEQ Quality Management Plan

Darwin Marine Supply Base HSEQ Quality Management Plan Darwin Marine Supply Base HSEQ Quality Management Plan REVISION SUMMARY Revision Date Comment Authorised 0 29.9.13 Initial input JC 1 12.1.15 General Review JC 2 3 4 5 6 7 8 9 Revision Log Revision No

More information

Cultural Diversity and Community Advisory Committee Charter

Cultural Diversity and Community Advisory Committee Charter Cultural Diversity and Community Advisory Committee Charter July 2015-2016 CONTENTS SECTION A: CULTURAL DIVERSITY AND COMMUNITY ADVISORY COMMITTEE CHARTER... 3 Statement of purpose... 3 1. Background and

More information

Cannabis Regulation in Canada:

Cannabis Regulation in Canada: Cannabis Regulation in Canada: Where We Came From, Where We Are and What s Coming Next Jonathan Sherman Cassels Brock & Blackwell LLP Sherri Altshuler Aird & Berlis LLP Canada, In Brief Right Now... Legal

More information